Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2026 Aug 6.
Published in final edited form as: Methods Mol Biol. 2025;2859:163–179. doi: 10.1007/978-1-0716-4152-1_9

The Functional Comparison of Eukaryotic Proteomes: Implications for Choosing an Appropriate Model Organism to Probe Human Biology

Hiren Karathia 1,2, Sridhar Hannenhalli 3,4, Rui Alves 5,6
PMCID: PMC13440527  NIHMSID: NIHMS2193258  PMID: 39436601

Abstract

Phenotypic differences between species are, in significant part, determined by their proteomic diversity. The link between proteomic and phenotypic diversity can be best understood in the context of the various pathways and biological processes in which proteins participate. While the conservation pattern for individual proteins across species is expected to follow the phylogenetic relationships among the species, the diversity patterns of individual pathways may not: certain pathways may be much more conserved among distantly related species than two closely related species, owing to the ecological histories of the species. Thus, a pathway-centric analysis of proteome conservation and diversity has important implications for the appropriate choice of a model organism when investigating specific aspects of human biology. Exploiting the complete genome sequences and protein-coding gene annotations, here we perform a comprehensive gene-set-centric analysis of proteomic diversity between humans and 54 eukaryotic organisms, resulting in a catalog of organisms that are most similar to humans in terms of specific pathways, processes, expression patterns, and diseases. We corroborate our findings using species-specific mass spectrometry data.

Our analysis provides a general framework to identify conserved and unique pathways in a group of organisms and a resource to prioritize appropriate model systems to study a specific biological system in a reference organism such as humans.

Keywords: The model organism, Orthology, Evolutionary-proteogenomics, Proteome, Network comparison

1. Introduction

Research in model organisms is a powerful tool to understand human biology. In general, proposing a model organism for a given biological process should be informed by similarities between organisms’ proteomes at various spatial, structural, and functional granularities [1]. Such comparisons enable a rational choice of the “average” organism to study a given process and extrapolate its functioning to the other organisms of the group [1]. This can reduce the number of organisms that one has to study in order to understand the molecular biology of a given process across the tree of life [2].

Broadly, the interspecies phenotypic conservation and differences are determined by the overall gene complement of a species and the spatiotemporal regulatory program of those genes. Many of the differences observed between closely related species are due to the regulation of gene expression and protein activity, probably encoded in the noncoding portion of the genome [3, 4]. Nevertheless, a significant part of the interspecies differences, especially in distant species, is due to differences in the complement of encoded proteins. Because proteins work cooperatively in functional pathways and biological processes [5], the phenotypic differences and commonality between species can be better understood via a “pathway”- or “biological process”-centric comparative analysis of genomes, as opposed to a protein-centric or protein family centric approach. However, there is a lack of comprehensive pathway-centric comparative analysis of eukaryotic proteomes.

The proteome of an organism can be approximately identified from its whole genome sequence and various in silico annotation approaches. However, the assignment of proteins in the proteome to specific tissues, organs, or any other physiologically or pathologically relevant set of proteins relies on experimental proteomics. Tandem Mass Spectrometry (MS/MS) proteomic datasets can be roughly grouped into distinct classes, defined in Box 1. However, analyzing such data is challenging because many peptide signals do not map to the reference proteome. This is either because they contain mutations, are novel peptides, or are alternative splicing products. While various strategies have been proposed to address these issues, those approaches are limited in various ways, including computational inefficiencies and errors when applied to large-scale studies [6–9].

Box 1: Contexts in Which the Proteome Is Studied.

Complete proteome:

An entire set of proteins coded in a genome of an organism, including alternative isoforms. The various terminologies below refer to various subsets of the complete proteome (or set of proteins encoced in a genome of an invidual organism):

Cellular proteome:

Proteins expressed in specific types of cells or tissues in specific environmental contexts.

Functional proteome:

Proteins for which functional information is available.

Enzymatic proteome:

Proteins with known enzymatic activity.

Receptor proteome:

Proteins that are known to be integral membrane proteins that recognize environmental signals and initiate signal transduction.

Ligand proteome:

Proteins that bind to receptors and trigger signal transduction.

Localized proteome:

Proteins present in specific subcellular compartments and components.

Transcriptional regulatory proteome:

Proteins that regulate transcription activity of genes via DNA binding.

Posttranslational modified proteome:

Proteins that are known to undergo chemical modifications of their amino acids, such as phosphorylation and ubiquitination.

Interacting proteome:

Proteins known to physically interact with other proteins.

Pathways proteome:

Proteins that are part of known biological pathways and processes.

A more comprehensive approach to identify novel peptides is proteogenomics. Proteogenomics is an area of research at the interface of proteomics and genomics that maps peptides identified in MS/MS experiments to nucleic acid regions that potentially code for proteins. MS/MS-based analysis in proteogenomics contributes to the measurement of peptides arising from expressed proteins, allowing for direct verification of coding regions of a genomic sequence. In addition to verifying protein-coding genes, proteogenomics confirms the expression of alternatively spliced variants in the eukaryotic genome. The broad goal of proteogenomics is to produce a complete quantitative species- and context-specific map of the proteome, including posttranslation modifications (PTM).

Based on the functional annotation of the genes and proteins as well as their gene expression profiles in multiple species, various comparative analyses have been performed: co-expression activity of genes based on orthology [10], differential expression analysis among species [11], and cross-species mapping of posttranslation modifications (PTM) [12] For instance, a recent comparative proteomic analysis suggested that proteins involved in the mammalian reproductive system have rapidly evolved under sexual selection [13]. Such comparative analyses would benefit from improved orthology mapping between pairs of species. Furthermore, improvements in the mapping of MS/MS spectra would also help identify paralog sequences in the reference genome [14] and help identify novel genes [15], both of which are critical to comparative analyses.

While a gene-centric comparative approach helps identify conserved genes and the evolution of individual genes and gene families, as mentioned above, to understand the conservation and diversification of biological processes and pathways, a pathway- or process-centric comparative approach is more suitable. In a pathway-centric comparative proteomic study, one must consider individual protein functions as well as the processes, pathways, and tissues in which each protein is involved, thus defining sets of proteins for such levels of functional abstraction. Given the variable accuracy and completeness across organisms in genome and proteome annotation, one also needs a way to transfer functional annotation from well-annotated to less well-annotated genomes.

This chapter describes a workflow to perform “pathway”--centric proteomic comparisons and applies that workflow to compare the human proteome to the proteomes of 54 other eukaryotes at different levels of functional abstraction. We use these comparisons to rank the nonhuman eukaryotes by their appropriateness as model organism candidates to study a particular functional context and to identify conservation and diversity between human and another 54 eukaryotic species relative to the particular function.

2. Materials

2.1. Proteome Sequences

The complete proteomes of Homo sapiens (20,125 proteins), Pan troglodytes (24,732 proteins), and Macaca mulatta (23,272 proteins) were downloaded from NCBI. The complete proteome of Gorilla gorilla (27,335 proteins) was downloaded from Ensembl (version 66.31). The complete proteomes of 51 eukaryotic organisms with fully sequenced genomes (Table 1) were downloaded from the KEGG database (December 2009), cross-referenced, and complemented with the corresponding proteomes found in the NCBI database.

Table 1.

Human-centric comparison of proteomes for 54 eukaryotes with fully sequenced genomes

OrgName Phylum Domain h-Oc h-Ac NHP nh-Oc nh-Ac
Homo sapiens (human) Vertebrates ANIMAL 20,125 0 – – –
Gorilla gorilla Vertebrates 19,510 615 27,473 26,106 1367
Mus musculus (mouse) Vertebrates 19,274 851 29,311 24,841 4470
Pan troglodytes (chimpanzee) Vertebrates 19,270 855 25,175 20,809 4366
Rattus norvegicus (rat) Vertebrates 19,132 993 26,157 23,597 2560
Macaca mulatta (rhesus monkey) Vertebrates 19,088 1037 23,998 21,206 2792
Bos taurus (cow) Vertebrates 18,214 1911 22,368 18,365 4003
Canis familiaris (dog) Vertebrates 18,205 1920 19,835 18,813 1022
Danio rerio (zebrafish) Vertebrates 17,946 2179 27,234 25,039 2195
Monodelphis domestica (opossum) Vertebrates 17,625 2500 19,157 16,943 2214
Xenopus tropicalis (western clawed frog) Vertebrates 15,778 4347 8741 8623 118
Drosophila melanogaster (fruit fly) Insects 14,526 5599 13,827 9434 4393
Xenopus laevis (African clawed frog) Vertebrates 14,473 5652 10,894 10,174 720
Drosophila pseudoobscura pseudoobscura Insects 14,468 5657 16,071 9819 6252
Aedes aegypti (yellow fever mosquito) Insects 14,214 5911 15,428 10,769 4659
Strongylocentrotus purpuratus (purple sea urchin) Echinoderms 13,955 6170 28,881 19,243 9638
Caenorhabditis elegans (Nematode) Nematodes 13,425 6700 20,185 9443 10,742
Brugia malayi (filaria) Nematodes 12,928 7197 11,371 6802 4569

Neurospora crassa Ascomycetes FUNGI 8911 11,214 9824 4113 5711
Aspergillus nidulans Ascomycetes 8848 11,277 9541 4691 4850
Laccaria bicolor Basidiomycetes 8727 11,398 18,215 4774 13,441
Aspergillus oryzae Ascomycetes 8722 11,403 12,074 5282 6792
Cryptococcus neoformans B-3501A Basidiomycetes 8653 11,472 6500 3767 2733
Debaryomyces hansenii Ascomycetes 8164 11,961 6324 3453 2871
Schizosaccharomyces pombe (fission yeast) Ascomycetes 8153 11,972 5003 3392 1611
Pichia stipitis Ascomycetes 8078 12,047 5816 3414 2402
Candida glabrata Ascomycetes 7743 12,382 5191 3117 2074
Fusarium graminearum Ascomycetes 7015 13,110 11,656 4094 7562
Cryptococcus neoformans JEC21 Basidiomycetes 6607 13,518 6273 3015 3258
Ustilago maydis Basidiomycetes 6598 13,527 6538 2970 3568
Magnaporthe grisea Ascomycetes 6235 13,890 14,010 3802 10,208
Kluyveromyces lactis Ascomycetes 5958 14,167 5335 2553 2782
Saccharomyces cerevisiae (budding yeast) Ascomycetes 5918 14,207 5881 2829 3052
Candida albicans Ascomycetes 4043 16,082 14,629 2093 12,536
Encephalitozoon cuniculi Microsporidians 3215 16,910 1996 879 1117

Arabidopsis thaliana (Thale cress) Dicotyledons PLANTS 9561 10,564 27,361 12,364 14,997
Oryza sativa japonica (Japanese rice) Monocotyledons 7375 12,750 26,937 9184 17,753
Ostreococcus lucimarinus Green algae 7029 13,096 7603 4010 3593
Cyanidioschyzon merolae Red algae 7028 13,097 5013 2932 2081
Chlamydomonas reinhardtii Green algae 6275 13,850 14,416 4480 9936

Monosiga brevicollis Choanoflagellates PROTISTS 8829 11,296 9171 4926 4245
Dictyostelium discoideum (cellular slime mold) Cellular slime molds 7685 12,440 13,437 5067 8370
Trypanosoma cruzi Euglenozoa 6781 13,344 19,607 7070 12,537
Entamoeba histolytica Entamoeba 6570 13,555 8162 4094 4068
Trypanosoma brucei Euglenozoa 6544 13,581 8712 3666 5046
Tetrahymena thermophila Alveolates 6307 13,818 24,770 6631 18,139
Plasmodium yoelii Alveolates 6227 13,898 7353 2291 5062
Trichomonas vaginalis Parabasalids 5058 15,067 59,679 7717 51,962
Leishmania major Euglenozoa 4683 15,442 8265 3015 5250
Plasmodium falciparum 3D7 Alveolates 4327 15,798 5263 1791 3472
Cryptosporidium parvum Alveolates 4313 15,812 3805 1615 2190
Cryptosporidium hominis Alveolates 4075 16,050 3885 1403 2482
Theileria annulata Alveolates 3879 16,246 3792 1473 2319
Theileria parva Alveolates 3586 16,539 4061 1453 2608
Giardia lamblia Diplomonads 2971 17,154 6502 1594 4908

20,125 human proteins were considered. Columns: NHP—total number of proteins in nonhuman proteomes. h-Oc— number of human proteins in Oc against the proteome of the target organism. nh-Oc—number of target proteins in Oc with the human proteome. h-Ac—number of human proteins absent in the proteome of the target organism. nh-Ac— number of target proteins absent in the human proteome

3. Methods

3.1. Homology Analysis

BLAST+ version 2.2.26 was downloaded from NCBI and used locally. All protein sequences were formatted using FormatDB. A pipeline that identifies various levels of homology (orthologs, domain orthologs, homologues) and classifies two proteomes relative to each other based on these relationships was developed and implemented using Python 2.7, Numpy (Numerical Python), Scipy, and Matplotlib.

3.2. Proteome Comparison and Classification

Comparison between the complete proteomes of any two organisms was performed as described previously [1]. In short, the proteomes are first BLASTed against each other. Afterwards, ortholog and homolog pairs are separated based on e-value, percentage identity, and aligned fraction. Figure 1 details the different groups of proteins generated from this analysis. Each protein of the total proteome from a human HP is blasted against the entire proteome of the target organism NHP. The set of ortholog (Oc) clusters are defined as all pairs that are matched with e-value<10−30 and an identity greater than 30% with coverage of alignment of over 80% of the human protein length. Homolog (Hc) clusters are defined as all pairs of proteins that are matched with an identity ≤30% with 10−30<e−value<10−04. Absent clusters (Ac) are defined as all proteins aligned with e-value>10−04. Complete protein sets in the Ac cluster further classify unique protein sets, each from a human and a nonhuman proteome, and construct sets as b−Ac (unique in human) and nb−Ac (unique in nonhuman).

Fig. 1.

Fig. 1

Integrative workflow of sequence-based orthology analysis and proteomics: The human proteome is BLASTed against the proteome of each organism from Table 1. Oc are clusters of human–nonhuman protein pairs whose alignment has −value≤10−30, and sequence identity > 30%over at least 80% of the alignment. Hc are clusters of human–nonhuman protein pairs whose alignment has 10−30<e−value≤10−4 and sequence identity ≤ 30%. The h−Ac are clusters of proteins unique to the human proteome that do not meet any of the previous quantitative criteria for OC and HC. The nh−AC are clusters of nonhuman proteins that do not meet any of the previous quantitative criteria for OC and HC

Because more than one protein may satisfy criteria under the homolog or ortholog clusters, we select the closest pair of the categories by assigning a score, “F-score,” to that of many-to-many related proteins, quantifying the similarity between a pair of proteins. We select those pairs of proteins that maximize the “F-score” independently within the Oc and Hc clusters. The “F-score” is defined as follows:

F-score=(F1+F2)−F3 (1)
F1=1−((S−I)/S) (2)

In Eq. 2, “S” represents the number of similar residues over the alignment, and “I” represents the number of identical residues. Both these values are outputs of BLAST. F1 is always between 0 and 1.

F2=(AL−G1−G2)/PL (3)

In Eq. 3, “G1” is the number of gaps within the aligned region of the query sequence, ‘G2’ is the number of gaps within the aligned region of the target sequence, “AL” represents the length of the alignment, and “PL” is the total length of the query sequence. F2 is always between 0 and 1.

F3=(G1/L1)+(G2/L2) (4)

In Eq. 4, “L1” is the length of the query sequence, and “L2” is the full length of the target sequence. F3 is always between 0 and 1.

Hence, “F-score” is always between 0 and 2, and the pair of proteins with the highest F-score in each Oc or Hc cluster is considered to be the functional orthologs or homologs, respectively.

We have benchmarked this procedure by BLASTing the human genome against itself and the baker’s yeast genome against itself. In every single case, the highest F-score is that of a protein with itself. Unlike the e-value, the F-score provides a measure that is symmetric between two proteomes. The highest F-score pair for an Oc between two organisms is always the same, whether the target genome is S or T.

Next, we used the Oc and Ac clusters for the analysis of functional evolution.

3.3. Functional ReAnnotation of the Human Proteome

To attribute biological processes, molecular functions, and cellular localization to each cluster, we downloaded the GOSLIM data for human and baker’s yeast from the GO database [16, 17]. We also downloaded data from KEGG that associates genes with KEGG metabolic circuits in fully sequenced genomes [18] and attributed pathway terms to each of the clusters.

3.4. Calculation of the Hamming Distance

The Hamming Distance (HD) between the vector V1→ of protein function associated with a specific process or pathway in humans and the vector V2→ of corresponding protein functions in another organism gives a measure of how different the two vectors are. It is calculated using the formula:

HD=∑i=1n1−δi

where δi is the Kronecker delta. δi is 1 if the elements in position i of both vectors are orthologs and 0 otherwise. The smaller the distance, the more similar the two vectors are, and the more similar the set of genes executing a specific process in both organisms. HD can be normalized (NHD) by dividing it by the maximum HD between the corresponding vectors of all organisms. Consequently, the smaller the NHD is, the more likely the other nonhuman eukaryote is a good model to study the relevant process or pathways and generalize the results for the other organism. The vectors we define for each pathway include all proteins that could participate in that pathway in all organisms in the KEGG database. This ensures that the comparison we are making accounts for differences between the pathway in humans and that in other organisms and vice-versa. All calculations were performed using Mathematica [19].

3.5. Proteomics Analysis

The species-specific experimental mass-spec data can be downloaded from different public repositories and transformed to mzML format using the MSConvertGUI tool integrated in ProteoWizard 3.0 [20]. Next, one can search spectra from each of the samples against the corresponding species-specific library of pre-identified spectra to which peptide sequences have been assigned through the SpectraST search engine incorporated in Trans Proteomic Pipeline (TPP) software. For this, one can download human and other eukaryotes-specific libraries from the PeptideAtlas website (http://www.peptideatlas.org/speclib/) in split format. Each species-specific sample in mzML can be input into the TPP-incorporated SpectraST tool for spectra searching and for downstream analysis of the matched spectra with protein sequences. For mapping identified peptides on protein sequences, one can use input FASTA files made of protein sequences, each from Oc clusters identified during comparison between human and nonhuman eukaryotes proteomes.

Further, one can validate the identified matched peptides using PeptideProphet and refine peptide-level analysis using iProphet search engines. For the selection of true-positive spectra, one can choose various statistical models available in the TPP SpectraST tool, such as the NRS model, number of sibling ions (NSI) model, number of sibling modifications (NSM) model, number of sibling searches (NSS) model, number of sibling experiments (NSE) model, and number of sibling peptides (NSP) model. In addition, one can normalize the sample peptides against the pI and hydrophobicity information about library peptides. Ultimately, the SpectraST-based search produces output in pepXML and protXML formats.

For the selection of significant signatures of peptides, one can input the pepXML into SkyLine tools [21] and compare those against sequences from randomly selected proteins in the same FASTA files that one had used during the previous peptide searching step. Ultimately, one can select the proteins whose peptides are mapped at FDR < 0.1 and consider these proteins as expressed candidates in the corresponding species-specific MS/MS data.

3.6. Results

3.6.1. Analysis Overview

We systematically compared the complete human proteome to that of 54 other eukaryotes with fully sequenced genomes using BLAST and separated the results into four main groups (Fig. 1):

  1. Cluster of orthologs (Oc), which includes proteins that have strong similarity to a specific human protein over the entire length of both proteins. Protein pairs in these clusters are deemed the most likely functional orthologs between the two proteomes.

  2. Cluster of homologs (Hc), which includes proteins that only have low sequence similarity to a specific human protein. Protein pairs in these clusters are deemed less functionally similar between the two proteomes.

  3. Clusters of human-only proteins (h−Ac), which include proteins in the human proteome that have no match to any proteins in the proteome of a compared eukaryote.

  4. Clusters of nonhuman proteins (nh−Ac), which include proteins in the proteome of a eukaryote that have no match to any proteins in the compared human proteome.

3.6.2. Large Scale Proteome Comparisons

Table 1 summarizes the Oc,Hc,h−Ac, and nh−Ac results of the comparison between the proteome of humans and that of each of the other 54 eukaryotic species. As one would expect, the proteome of humans is most similar to that of other vertebrates. The vertebrate with a proteome having the least similarity to that of humans is the African clawed frog. Among all human proteins, 28% have no strong sequence match in the frog proteome, whereas only 7% of the frog proteins are absent in humans. On the opposite end of the scale, and to our surprise, gorillas have a proteome that is most similar to that of humans. Among all human proteins, 3% have no sequence match to the proteome of gorillas, while 5% of the gorilla proteins are absent in the human proteome. The corresponding numbers in Chimpanzees, which are phylogenetically closer to humans than Gorillas, are 4% and 17%, respectively (see Table 1).

The non-vertebrate species with a proteome that is closest to that of humans is Drosophila melanogaster, while the least similar proteome is that of Brugia malayi (filaria). Only 64% of the human proteins have at least one homolog in B. malayi, while 40% of this protein are absent in humans.

Our results broadly follow the known phylogeny: in the decreasing order of proteome similarity with humans, the eukaryotic clades are: Animals, Fungi, Plants, and Protista. Giardia lamblia is an eukaryotic organism with a proteome that is the most dissimilar to that of humans, with only 15% of its proteins being present in humans. Overall, only 1250 human proteins are consistently conserved throughout the 54 nonhuman eukaryotes. In addition, 180 proteins are unique to humans and absent in all other eukaryotes.

3.6.3. Similarities and Differences in Process-Associated Proteomes Between Other Eukaryotes and Humans

Oc and, to a least extent, h−Ac clusters identify proteins with similar functions. By focusing on these clusters and mapping their proteins to functional gene groups, one can compare functional similarity and divergence between humans and other eukaryotes. Proteins in the Oc cluster are more likely to share the same function in different organisms. Thus, these clusters permit studying functional conservation between organisms with higher confidence level, identifying the best alternative organism(s) in which to study a given process that cannot be studied for various reasons in humans.

Figure 2 summarizes how the protein complement associated with broad functional categories is conserved between humans and other eukaryotes. Overall, the conservation of the complement of proteins associated with each category follows a phylogenetic pattern. The functional category with the highest degree of conservation in its protein complement is catalytic proteins, followed by the substrate proteins functional category. Conservation of protein functions in this set is very high among animals and decreases between animals and more distant phyla, suggesting that the metabolism of animals is, in general, similar. In fact, the fraction of human proteins from the catalytic protein set that is absent from all other eukaryotes is minimal (<15% of the total human catalytic proteins).

Fig. 2.

Fig. 2

Summary for comparison of human-specific broad functional categories associated with conserved and unique proteins respectively identified in Oc*(a) and h−Ac*(b) clusters: Each row summarizes the results for an organism. Each column summarizes the results for a broad functional category of the proteome. The greener the square, the more similar in the case of A (or more dissimilar in case of B), the protein set associated with the functional category of the column in the organism of the row is to the correspondent human protein set. The redder the square, the less similar in case of A (or more similar in case of B), the protein set associated with the functional category of the column in the organism of the row is to the correspondent human protein set. *(a): Cluster of orthologs (Oc), which includes proteins that have strong similarity to a specific human protein over the entire length of both proteins. Protein pairs in these clusters are deemed the most likely the closest functional orthologs between the two proteomes. *(b): Clusters of human-only proteins (h−Ac), which include proteins in the human proteome that have no match to any proteins in the proteome of a compared eukaryote

In contrast, the functional categories receptors, immunologic proteins, and ligands have the lowest degree of protein conservation between humans and other eukaryotes. This argues for the species specificity of these classes of proteins and their potential role in phenotypic diversity [22, 23].

3.6.4. Tissue- and Organ-Specific Proteome Analysis

Here we compare the fraction of the proteome that is specifically expressed in various human tissues/organs or that is secreted with the proteome of other eukaryotes. Figure 3 summarizes the results.

Fig. 3.

Fig. 3

Summary of protein conservation for the human proteome in specific tissues: Each column summarizes the results for an organism. Each row summarizes the results for a broad functional category. The greener the square, the more similar the protein set associated with the functional category of the row in the organism of the column is to the correspondent human protein set. The redder the square, the less similar the protein set associated with the functional category of the row in the organism of the column is to the correspondent human protein set

The tissue-specific proteomes with the highest degree of conservation in eukaryotes are those associated specifically with lacrimal glands (452 proteins) and tears (459 proteins). The proteins from these sets have functional orthologs in all animals and some lower eukaryotes. Interestingly, functional orthologs for the human proteins CACNA1D, KCNN3, and PRR4 are found in all animals except for the African clawed frog. The first three proteins regulate calcium and potassium channels and their activities, while the last one appears to play a role in stabilizing the tear film, protecting the ocular surface of the eyes in humans [24], whereas in the African clawed frog, these proteins are functional in left–right asymmetry during eye development [25].

The set of proteins associated with most types of reproductive tissues in humans is highly conserved in mammals. For example, PAEP (progestagen-associated endometrial protein, Entrez gene id 5047) is conserved in all mammals. This glycoprotein contributes to making the uterine environment suitable for reproduction and is used for predicting pregnancy following an in vitro fertilization (IVF) cycle [26]. In contrast, protein sets from the urethra, human scalp, and seminal vesicle are only highly conserved in primates.

Our analysis also highlights that olfactory tract-specific proteins have a degree of conservation in a large fraction of eukaryotic organisms. Such conservation is a further indication that the mechanisms for nutrient detection and environmental recognition evolved from an original rudimentary set of proteins, as suggested by [27].

There are some interesting differences between primates with respect to the conservation of some individual tissue-specific proteins. For example, GHRL (ghrelin/obestatin prepropeptide, gene-ID: 51738) is annotated as being specifically expressed in the vena cava. This protein is absent in chimps and is present in other primates. It regulates growth hormone release and is involved in inhibiting thirst and anxiety [28]. It is also a good marker for studying type-2 diabetes and obesity [29], ischemic stroke [30], cardiovascular functions [31], and Rett syndrome [28]. Its absence in chimps suggests that other primates would be better models for studying aspects of these diseases, specifically those involving GHRL.

4. Discussion

Here, we sketch a systematic approach to compare the proteome of an organism to that of others with respect to specific processes, pathways, and tissues. We focus on the human proteome as the reference. This allows us to rank various organisms in order of similarity to humans for each of the categories in the analysis, creating an approach and resource for human-centric comparative eukaryotic proteomics.

Previous work has used a similar approach as ours to identify “phenologs,” i.e., equivalence between a human disease and a phenotype in five other organisms, based on protein similarity between the two sets—disease-associated proteins in humans and phenotype-associated proteins in the other species [32, 33]. Our work has a different goal and a substantially greater scope with 54 eukaryotes and protein sets corresponding to biological processes, pathways, protein families, tissue specificity, etc.

One limitation of our study is that it is contingent on the quality and completeness of protein annotation in different species, which is variable across species. However, to minimize this concern, we carefully combined the annotations from NCBI and the Sanger center. Another data-related limitation is the functional annotations in various genomes. However, this is somewhat mitigated in our human-centric study as we refer only to human functional annotations, which are continuously improving.

Another limitation is the fact that we used extreme sequence similarity as a proxy for functional orthology and a lack of sequence similarity as a proxy for the absence of the protein in one of the species. Although this is not always true, using sequence similarity to infer functional orthology was shown to be more accurate than using structure and other protein features. Although large sets of experimentally characterized functional orthologs are not available to benchmark any of these methods, our specific pipeline, although based on arbitrary significance thresholds, should be considered stringent. Moreover, our pipeline is flexible and can be customized for specific needs.

The results above rely only on the protein annotation of genomes and the functional annotation of the proteins, and as such lack information about physiological contexts. Here we discuss how one can corroborate and refine such comparisons using experimental MS/MS data to assess the expression of proteins in specific physiological contexts. One can qualitatively and quantitatively identify the expression of the ortholog proteins independently from species-specific MS/MS data. One can identify the human and other eukaryotic proteins in each Oc cluster and map species-specific MS/MS spectra on top of the sequence of the ortholog proteins (see method section). One can also map the species-specific MS/MS spectra on top of the protein sequences in the h−Ac and nh−Ac clusters, respectively, identified as unique proteins from humans and eukaryotes, in order to identify novel proteins in a species that might not be identified by the conventional method of mapping the species-specific MS/MS data directly to that species proteome.

5. Conclusion

In summary, we have reported the first comprehensive survey of gene set-centric conservation of the proteome between humans and 54 eukaryotes that have complete genome sequences and protein annotations. Our results should serve as an important resource for investigating the evolution of specific processes and for prioritizing model organisms to investigate specific aspects of human biology, including diseases.

References

  • 1.Karathia H, Vilaprinyo E, Sorribas A, Alves R (2011) Saccharomyces cerevisiae as a model organism: a comparative study. PLoS One 6:e16015. 10.1371/journal.pone.0016015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Russell JJ, Theriot JA, Sood P, Marshall WF, Landweber LF, Fritz-Laylin L, Polka JK, Oliferenko S, Gerbich T, Gladfelter A, Umen J, Bezanilla M, Lancaster MA, He S, Gibson MC, Goldstein B, Tanaka EM, Hu CK, Brunet A (2017) Non-model model organisms. BMC Biol 15:55. 10.1186/s12915-017-0391-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Somel M, Liu X, Tang L, Yan Z, Hu H, Guo S, Jiang X, Zhang X, Xu G, Xie G, Li N, Hu Y, Chen W, Pääbo S, Khaitovich P (2011) MicroRNA-driven developmental remodeling in the brain distinguishes humans from other primates. PLoS Biol 9:e1001214. 10.1371/journal.pbio.1001214 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Crisci JL, Wong A, Good JM, Jensenf JD (2011) On characterizing adaptive events unique to modern humans. Genome Biol Evol 3:791–798. 10.1093/gbe/evr075 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Westerhoff HV, Winder C, Messiha H, Simeonidis E, Adamczyk M, Verma M, Bruggeman FJ, Dunn W (2009) Systems biology: the elements and principles of life. FEBS Lett 583:3882–3890 [DOI] [PubMed] [Google Scholar]
  • 6.Dasari S, Chambers MC, Slebos RJ, Zimmerman LJ, Ham AJL, Tabb DL (2010) TagRecon: high-throughput mutation identification through sequence tagging. J Proteome Res 9:1716–1726. 10.1021/pr900850m [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Ma ZQ, Chambers MC, Ham AJL, Cheek KL, Whitwell CW, Aerni HR, Schilling B, Miller AW, Caprioli RM, Tabb DL (2011) ScanRanker: quality assessment of tandem mass spectra via sequence tagging. J Proteome Res 10: 2896–2904. 10.1021/pr200118r [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Frank A, Pevzner P (2005) PepNovo: De novo peptide sequencing via probabilistic network modeling. Anal Chem 77:964–973. 10.1021/ac048788h [DOI] [PubMed] [Google Scholar]
  • 9.Zhang J, Xin L, Shan B, Chen W, Xie M, Yuen D, Zhang W, Zhang Z, Lajoie GA, Ma B (2012) PEAKS DB: De novo sequencing assisted database search for sensitive and accurate peptide identification. Mol Cell Proteomics 11(M111):010587. 10.1074/mcp.M111.010587 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Gerstein MB, Rozowsky J, Yan KK, Wang D, Cheng C, Brown JB, Davis CA, Hillier L, Sisu C, Li JJ, Pei B, Harmanci AO, Duff MO, Djebali S, Alexander RP, Alver BH, Auerbach R, Bell K, Bickel PJ, Boeck ME, Boley NP, Booth BW, Cherbas L, Cherbas P, Di C, Dobin A, Drenkow J, Ewing B, Fang G, Fastuca M, Feingold EA, Frankish A, Gao G, Good PJ, Guigó R, Hammonds A, Harrow J, Hoskins RA, Howald C, Hu L, Huang H, Hubbard TJP, Huynh C, Jha S, Kasper D, Kato M, Kaufman TC, Kitchen RR, Ladewig E, Lagarde J, Lai E, Leng J, Lu Z, MacCoss M, May G, McWhirter R, Merrihew G, Miller DM, Mortazavi A, Murad R, Oliver B, Olson S, Park PJ, Pazin MJ, Perrimon N, Pervouchine D, Reinke V, Reymond A, Robinson G, Samsonova A, Saunders GI, Schlesinger F, Sethi A, Slack FJ, Spencer WC, Stoiber MH, Strasbourger P, Tanzer A, Thompson OA, Wan KH, Wang G, Wang H, Watkins KL, Wen J, Wen K, Xue C, Yang L, Yip K, Zaleski C, Zhang Y, Zheng H, Brenner SE, Graveley BR, Celniker SE, Gingeras TR, Waterston R (2014) Comparative analysis of the transcriptome across distant species. Nature 512:445–448. 10.1038/nature13424 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Zhu Y, Li M, Sousa AMM, Šestan N (2014) XSAnno: a framework for building ortholog models in cross-species transcriptome comparisons. BMC Genomics 15. 10.1186/1471-2164-15-343 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Chaudhuri R, Sadrieh A, Hoffman NJ, Parker BL, Humphrey SJ, Stöckli J, Hill AP, James DE, Yang JYH (2015) PhosphOrtholog: a web-based tool for cross-species mapping of orthologous protein post-translational modifications. BMC Genomics 16:617. 10.1186/s12864-015-1820-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Bayram HL, Claydon AJ, Brownridge PJ, Hurst JL, Mileham A, Stockley P, Beynon RJ, Hammond DE (2016) Cross-species proteomics in analysis of mammalian sperm proteins. J Proteome 135:38–50. 10.1016/j.jprot.2015.12.027 [DOI] [PubMed] [Google Scholar]
  • 14.Lee H, Schatz MC (2012) Genomic dark matter: the reliability of short read mapping illustrated by the genome mappability score. Bioinformatics 28:2097–2105. 10.1093/bioinformatics/bts330 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Rödelsperger C (2018) Comparative genomics of gene loss and gain in Caenorhabditis and other nematodes. In: Setubal JC, Stoye J, Stadler PF (eds) Comparative genomics: methods and protocols. Springer, New York, pp 419–432 [DOI] [PubMed] [Google Scholar]
  • 16.Hirschman JE (2006) Genome Snapshot: a new resource at the Saccharomyces Genome Database (SGD) presenting an overview of the Saccharomyces cerevisiae genome. Nucleic Acids Res 34:D442–D445. 10.1093/nar/gkj117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Hong EL, Balakrishnan R, Dong Q, Christie KR, Park J, Binkley G, Costanzo MC, Dwight SS, Engel SR, Fisk DG, Hirschman JE, Hitz BC, Krieger CJ, Livstone MS, Miyasato SR, Nash RS, Oughtred R, Skrzypek MS, Weng S, Wong ED, Zhu KK, Dolinski K, Botstein D, Cherry JM (2008) Gene ontology annotations at SGD: new data sources and annotation methods. Nucleic Acids Res 36:D577. 10.1093/nar/gkm909 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Okuda S, Yamada T, Hamajima M, Itoh M, Katayama T, Bork P, Goto S, Kanehisa M (2008) KEGG atlas mapping for global analysis of metabolic pathways. Nucleic Acids Res 36: W423. 10.1093/nar/gkn282 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Hastings C, Mischo K, Morrison M (2015) Hands-On Start to Wolfram Mathematica. WolframMedia, p 469 [Google Scholar]
  • 20.Chambers MC, MacLean B, Burke R, Amodei D, Ruderman DL, Neumann S, Gatto L, Fischer B, Pratt B, Egertson J, Hoff K, Kessner D, Tasman N, Shulman N, Frewen B, Baker TA, Brusniak MY, Paulse C, Creasy D, Flashner L, Kani K, Moulding C, Seymour SL, Nuwaysir LM, Lefebvre B, Kuhlmann F, Roark J, Rainer P, Detlev S, Hemenway T, Huhmer A, Langridge J, Connolly B, Chadick T, Holly K, Eckels J, Deutsch EW, Moritz RL, Katz JE, Agus DB, MacCoss M, Tabb DL, Mallick P (2012) Across-platform toolkit for mass spectrometry and proteomics. Nat Biotechnol 30:918–920 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.MacLean B, Tomazela DM, Shulman N, Chambers M, Finney GL, Frewen B, Kern R, Tabb DL, Liebler DC, MacCoss MJ (2010) Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26:966–968. 10.1093/bioinformatics/btq054 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Barreiro LB, Marioni JC, Blekhman R, Stephens M, Gilad Y (2010) Functional comparison of innate immune signaling pathways in primates. PLoS Genet 6:1–13. 10.1371/journal.pgen.1001249 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Kumar S, Qiu H, Oezguen N, Herlyn H, Halpert JR, Wojnowski L (2009) Ligand diversity of human and chimpanzee CYP3A4: activation of human CYP3A4 by lithocholic acid results from positive selection. Drug Metab Dispos 37:1328–1333. 10.1124/dmd.108.024372 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Perumal N, Funke S, Pfeiffer N, Grus FH (2014) Characterization of lacrimal proline-rich protein 4 (PRR4) in human tear proteome. Proteomics 14:1698–1709. 10.1002/pmic.201300039 [DOI] [PubMed] [Google Scholar]
  • 25.Pai VP, Vandenberg LN, Blackiston D, Levin M (2012) Neurally derived tissues in xenopus laevis embryos exhibit a consistent bioelectrical left-right asymmetry. Stem Cells Int 2012:1. 10.1155/2012/353491 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Bentin-Ley U, Lindhard A, Ravn V, Islin H, Sørensen S (2011) Glycodelin in endometrial flushing fluid and endometrial biopsies from infertile and fertile women. Eur J Obstet Gynecol Reprod Biol 156:60–66. 10.1016/j.ejogrb.2010.12.040 [DOI] [PubMed] [Google Scholar]
  • 27.Ye K, Gu Z (2011) Recent advances in understanding the role of nutrition in human genome evolution. Adv Nutr 3:486–496. 10.3945/an.111.001024.FIGURE [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Hara M, Nishi Y, Yamashita Y, Yoh J, Takahashi S, Nagamitsu S-I, Kakuma T, Hosoda H, Kangawa K, Kojima M, Matsuishi T (2011) Ghrelin levels are reduced in Rett syndrome patients with eating difficulties. Int J Dev Neurosci Off J Int Soc Dev Neurosci 29: 899–902. 10.1016/j.ijdevneu.2011.07.003 [DOI] [PubMed] [Google Scholar]
  • 29.Churm R, Davies JS, Stephens JW, Prior SL (2016) Ghrelin function in human obesity and type 2 diabetes: a concise review. Obes Rev Off J Int Assoc Study Obes 18:140–148. 10.1111/obr.12474 [DOI] [PubMed] [Google Scholar]
  • 30.Seyhanli ES, Lok U, Gulacti U, Buyukaslan H, Atescelik M, Yildiz M, Onur MR, Goktekin MC, Aydın S (2015) Assessment of serum and urine ghrelin levels in patients with acute stroke. Int J Clin Exp Med 8:722–729 [PMC free article] [PubMed] [Google Scholar]
  • 31.Khatib MN, Shankar A, Kirubakaran R, Agho K, Simkhada P, Gaidhane S, Saxena D, Unnikrishnan B, Gode D, Gaidhane A, Zahiruddin SQ (2015) Effect of Ghrelin on mortality and cardiovascular outcomes in experimental rat and mice models of heart failure: a systematic review and meta-analysis. PLoS One 10:e0126697. 10.1371/journal.pone.0126697 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.McGary KL, Park TJ, Woods JO, Cha HJ, Wallingford JB, Marcotte EM (2010) Systematic discovery of nonobvious human disease models through orthologous phenotypes. Proc Natl Acad Sci 107:6544–6549. 10.1073/pnas.0910200107 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Lee I, Blom UM, Wang PI, Shim JE, Marcotte EM (2011) Prioritizing candidate disease genes by network-based boosting of genomewide association data. Genome Res 21:1109–1121. 10.1101/gr.118992.110 [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES